Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative γδ T cells

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 3915-3923

  Bourgarit, Anne ^a,b   Carcelain, Guislaine ^a   Samri, Assia ^a   Parizot, Christophe ^a   Lafaurie, Matthieu ^b   Abgrall, Sophie ^c   Delcey, Veronique ^d   Vicaut, Eric ^e   Sereni, Daniel ^b   Autran, Brigitte ^a   Begle A M ^f   Besse, F ^f   Bollens, D ^f   Bouchaud, O ^f   Bursachi, P ^f   Cadranel, J ^f   Camuset, J ^f   Chakvetadze, C ^f   Delgado, J ^f   Diemer, M ^f   Dupont, B ^f   Elmarsafy, S ^f   Fain, O ^f   Fonquernie, L ^f   Furco, A ^f   Girard, P M ^f   Grillot Courvalin, C ^f   Grivois, J F ^f   Guignet, A ^f   Guilleminot, M C ^f   Herrmann, J L ^f   Jeantils, V ^f   Joly, V ^f   Jouis, V ^f   Klutse, P ^f   Lacombe, K ^f   Lahoulou, R ^f   Lascoux, C ^f   Lavole, A ^f   Lefebvre, B ^f   Lefort, A ^f   Letellier, E ^f   Lortholary, O ^f   Martinez, V ^f   Metro, A ^f   Trumeau, M ^f   Meynard, J L ^f   Meyohas, M C ^f   Molina, J M ^f   Obenga, G ^f   Parrinello, M ^f   Pelet, O ^f   Pintado, C ^f   Ponscarme, D ^f   Rami, A ^f   Rozenbaum, W ^f   Sahli, H ^f   Sellier, P ^f   Slama, L ^f   Courtial, S ^f   Tubiana, R ^f   Stirnemann, J ^f   Tassi, S ^f   Taulera, O ^f   Touitou, H ^f   Vacher, I ^f   Vincent, F ^f   Yeni, P ^f   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔPITAL FERNAND WIDAL   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ANTIRETROVIRUS AGENT; CD94 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; NATURAL KILLER CELL RECEPTOR; PROTEIN NKG2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TOLL LIKE RECEPTOR 2; TUBERCULIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; T CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VDELTA2, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; MYCOBACTERIUM; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RISK FACTOR; T LYMPHOCYTE; TH1 CELL; TUBERCULIN TEST; TUBERCULOSIS; CASE CONTROL STUDY; CELL COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; MICROBIOLOGY; MIDDLE AGED;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CELL COUNT; DENDRITIC CELLS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, KIR; T-LYMPHOCYTES; TH1 CELLS; TUBERCULIN; TUBERCULOSIS;

EID: 70349313108     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804020     Document Type: Article

References (43)

1. Lawn, S. D., L. G. Bekker, and R. F. Miller. 2005. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect. Dis. 5: 361-373.
2. Race, E. M., J. Adelson-Mitty, G. R. Kriegel, T. F. Barlam, K. A. Reimann, N. L. Letvin, and A. J. Japour. 1998. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 351: 252-255.
3. Narita, M., D. Ashkin, E. S. Hollender, and A. E. Pitchenik. 1998. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am. J. Respir. Crit. Care Med. 158: 157-161. (Pubitemid 28337174)
4. Bourgarit, A., G. Carcelain, V. Martinez, C. Lascoux, V. Delcey, B. Gicquel, E. Vicaut, P. H. Lagrange, D. Sereni, and B. Autran. 2006. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20: F1-F7.
5. Flynn, J. L., and J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12: 432-436.
6. Li, T. S., R. Tubiana, C. Katlama, V. Calvez, H. Ait Mohand, and B. Autran. 1998. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351: 1682-1686.
7. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116. (Pubitemid 27450659)
8. Hengel, R. L., M. C. Allende, R. L. Dewar, J. A. Metcalf, J. M. Mican, and H. C. Lane. 2002. Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 18: 969-975.
9. Wendland, T., H. Furrer, P. L. Vernazza, K. Frutig, A. Christen, L. Matter, R. Malinverni, and W. J. Pichler. 1999. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS 13: 1857-1862.
10. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168: 1294-1301. (Pubitemid 34094498)
11. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167: 910-918.
12. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163: 3920-3927. (Pubitemid 29450920)
13. Stenger, S., and R. L. Modlin. 2002. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14: 452-457. (Pubitemid 34671247)
14. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. Vandenbroucke-Grauls, B. Appelmelk, and Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197: 7-17.
15. Grassi, F., A. Hosmalin, D. McIlroy, V. Calvez, P. Debre, and B. Autran. 1999. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 13: 759-766. (Pubitemid 29224577)
16. Lichtner, M., R. Rossi, F. Mengoni, S. Vignoli, B. Colacchia, A. P. Massetti, I. Kamga, A. Hosmalin, V. Vullo, and C. M. Mastroianni. 2006. Circulating dendritic cells and interferon-α production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clin. Exp. Immunol. 143: 329-337.
17. Schmidt, B., S. H. Fujimura, J. N. Martin, and J. A. Levy. 2006. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. J. Clin. Immunol. 26: 55-64. (Pubitemid 43112625)
18. Zhang, Z., J. Fu, Q. Zhao, Y. He, L. Jin, H. Zhang, J. Yao, L. Zhang, and F. S. Wang. 2006. Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy. J. Immunol. 176: 5644-5651.
19. Flo, T. H., O. Halaas, S. Torp, L. Ryan, E. Lien, B. Dybdahl, A. Sundan, and T. Espevik. 2001. Differential expression of Toll-like receptor 2 in human cells. J. Leukocyte Biol. 69: 474-481. (Pubitemid 32221453)
20. Tanaka, Y., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375: 155-158.
21. Shen, Y., D. Zhou, L. Qiu, X. Lai, M. Simon, L. Shen, Z. Kou, Q. Wang, L. Jiang, J. Estep, et al. 2002. Adaptive immune response of Vγ2Vδ2+ T cells during mycobacterial infections. Science 295: 2255-2258.
22. Hoft, D. F., R. M. Brown, and S. T. Roodman. 1998. Bacille Calmette-Guerin vaccination enhances human γδT cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161: 1045-1054.
23. Kabelitz, D., A. Bender, S. Schondelmaier, B. Schoel, and S. H. Kaufmann. 1990. A large fraction of human peripheral blood γδ+ T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J. Exp. Med. 171: 667-679. (Pubitemid 20088974)
24. Autran, B., F. Triebel, C. Katlama, W. Rozenbaum, T. Hercend, and P. Debre. 1989. T cell receptor γδ+ lymphocyte subsets during HIV infection. Clin. Exp. Immunol. 75: 206-210. (Pubitemid 19074247)
25. Carvalho, A. C., A. Matteelli, P. Airo, S. Tedoldi, C. Casalini, L. Imberti, G. P. Cadeo, A. Beltrame, and G. Carosi. 2002. γδ T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection. Thorax 57: 357-360. (Pubitemid 34298936)
26. Boullier, S., M. Cochet, F. Poccia, and M. L. Gougeon. 1995. CDR3-independent γδ Vδ 1+ T cell expansion in the peripheral blood of HIV-infected persons. J. Immunol. 154: 1418-1431.
27. Rojas, R. E., K. A. Chervenak, J. Thomas, J. Morrow, L. Nshuti, S. Zalwango, R. D. Mugerwa, B. A. Thiel, C. C. Whalen, and W. H. Boom. 2005. Vδ2+ γδ T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay. J. Infect. Dis. 192: 1806-1814.
28. Gioia, C., C. Agrati, R. Casetti, C. Cairo, G. Borsellino, L. Battistini, G. Mancino, D. Goletti, V. Colizzi, L. P. Pucillo, and F. Poccia. 2002. Lack of CD27-CD45RA-Vγ9Vδ2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J. Immunol. 168: 1484-1489.
29. Shen, L., Y. Shen, D. Huang, L. Qiu, P. Sehgal, G. Z. Du, M. D. Miller, N. L. Letvin, and Z. W. Chen. 2004. Development of Vγ2Vδ2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells. J. Infect. Dis. 190: 1438-1447.
30. Poles, M. A., S. Barsoum, W. Yu, J. Yu, P. Sun, J. Daly, T. He, S. Mehandru, A. Talal, M. Markowitz, A. Hurley, D. Ho, and L. Zhang. 2003. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood γδ T cells despite suppressive therapy. J. Virol. 77: 10456-10467.
31. Boullier, S., Y. Poquet, F. Halary, M. Bonneville, J. J. Fournie, and M. L. Gougeon. 1998. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vγ9Vδ2 T cells but not on CD94- thymic or mature γδ T cell clones. Eur. J. Immunol. 28: 3399-3410.
32. Fausther-Bovendo, H., N. Wauquier, J. Cherfils-Vicini, I. Cremer, P. Debre, and V. Vieillard. 2008. NKG2C is a major triggering receptor involved in the Vδ1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells. AIDS 22: 217-226.
33. French, M. A., P. Price, and S. F. Stone. 2004. Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627.
34. Dhasmana, D. J., K. Dheda, P. Ravn, R. J. Wilkinson, and G. Meintjes. 2008. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 68: 191-208.
35. Tan, D. B., Y. K. Yong, H. Y. Tan, A. Kamarulzaman, L. H. Tan, A. Lim, I. James, M. French, and P. Price. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 9: 307-316.
36. Meintjes, G., K. A. Wilkinson, M. X. Rangaka, K. Skolimowska, K. van Veen, M. Abrahams, R. Seldon, D. J. Pepper, K. Rebe, P. Mouton, et al. 2008. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 178: 1083-1089.
37. Millington, K. A., J. A. Innes, S. Hackforth, T. S. Hinks, J. J. Deeks, D. P. Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178: 5217-5226.
38. Egen, J. G., A. G. Rothfuchs, C. G. Feng, N. Winter, A. Sher, and R. N. Germain. 2008. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28: 271-284.
39. Price, P., C. Witt, D. de Santis, and M. A. French. 2007. Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J. Acquired Immune Defic. Syndr. 45: 359-361.
40. Vannberg, F. O., S. J. Chapman, C. C. Khor, K. Tosh, S. Floyd, D. Jackson-Sillah, A. Crampin, L. Sichali, B. Bah, P. Gustafson, et al. 2008. CD209 genetic polymorphism and tuberculosis disease. PLoS ONE 3: e1388.
41. Thuong, N. T., T. R. Hawn, G. E. Thwaites, T. T. Chau, N. T. Lan, H. T. Quy, N. T. Hieu, A. Aderem, T. T. Hien, J. J. Farrar, and S. J. Dunstan. 2007. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun. 8: 422-428.
42. Boulware, D., D. Meya, T. Bergemann, I. Vlasova, A. Kambugu, K. P. McAdam, E. Janoff, and P. Bohjanen. 2008. Biomarkers of immune activation are predictors of HIV Immune Reconstitution Inflammatory Syndrome. In 15th Conference on Retroviruses and Opportunistic Infections (CROI), February 3-6, Boston. Poster 1007.
43. Hochberg, Y., and Y. Benjamini. 1990. More powerful procedures for multiple significance testing. Stat. Med. 9: 811-818.